HomeVFY • ASX
add
Vitrafy Life Sciences Ltd
Previous close
$1.30
Day range
$1.30 - $1.35
Year range
$1.08 - $2.10
Market cap
55.39M AUD
Avg Volume
20.82K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 155.12K | -63.72% |
Operating expense | 5.71M | 69.57% |
Net income | -3.51M | 32.29% |
Net profit margin | -2.26K | -86.62% |
Earnings per share | — | — |
EBITDA | -4.37M | -143.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.57M | 203.32% |
Total assets | 31.84M | 225.74% |
Total liabilities | 3.08M | -91.05% |
Total equity | 28.77M | — |
Shares outstanding | 63.85M | — |
Price to book | 2.89 | — |
Return on assets | -34.49% | — |
Return on capital | -37.67% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.51M | 32.29% |
Cash from operations | -2.39M | -92.56% |
Cash from investing | 4.96M | 287,614.48% |
Cash from financing | -37.72K | -101.39% |
Net change in cash | 2.53M | 73.44% |
Free cash flow | -3.20M | -60.16% |
About
Founded
2017
Website
Employees
22
